Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Ligand Binding Sites02:40

Ligand Binding Sites

11.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
11.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.2K
Conserved Binding Sites01:49

Conserved Binding Sites

4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

10.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
10.6K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

794
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
794

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oligonucleotide-siRNA conjugate for SOD1 amyotrophic lateral sclerosis: a phase 1 trial.

Nature medicine·2026
Same author

Clinical nurses as digital guardians: unlocking the key determinants of digital resilience in the AI era.

Frontiers in public health·2026
Same author

DOCKweb: a web-based GUI platform for molecular modeling with DOCK6.

Journal of computer-aided molecular design·2026
Same author

Effectiveness of a cluster management strategy on maternal and neonatal outcomes in high-risk pregnancies with hypertensive disorders: a retrospective cohort study.

Frontiers in global women's health·2026
Same author

Change Fatigue and Attitudes Toward AI in County-Level Nurses: The Mediating Role of AI Literacy.

Journal of nursing management·2026
Same author

Metavirome Analysis of Viruses Carried by Dairy Cows in Shaanxi, Gansu and Ningxia, China.

Animals : an open access journal from MDPI·2026

Related Experiment Video

Updated: Apr 23, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K

Pharmacophore-based similarity scoring for DOCK.

Lingling Jiang1, Robert C Rizzo

  • 1Department of Applied Mathematics & Statistics, ‡Institute of Chemical Biology & Drug Discovery, §Laufer Center for Physical & Quantitative Biology, Stony Brook University , Stony Brook, New York 11794-3600, United States.

The Journal of Physical Chemistry. B
|September 18, 2014
PubMed
Summary

This study introduces a new pharmacophore matching similarity (FMS) scoring function for DOCK software, significantly improving drug lead discovery through enhanced pose reproduction and virtual screening success.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

270

Related Experiment Videos

Last Updated: Apr 23, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

2.1K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

270

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Structural bioinformatics

Background:

  • Pharmacophore modeling is crucial for rational drug design by integrating molecular features.
  • Existing scoring functions in molecular docking can be improved for greater accuracy.

Purpose of the Study:

  • To encode a 3D pharmacophore matching similarity (FMS) scoring function into the DOCK program.
  • To validate and characterize the performance of the FMS scoring method.
  • To enhance computational drug discovery through improved virtual screening.

Main Methods:

  • Incorporation of FMS scoring into the DOCK software.
  • Validation using pose reproduction, crossdocking, and enrichment studies.
  • Application to diverse protein families and clinical drug targets (EGFR, IGF-1R, HIVgp41).

Main Results:

  • FMS scoring alone improved pose reproduction to 93.5% and reduced sampling failures to 3.7%.
  • Combined FMS+SGE scoring achieved 98.3% success in pose reproduction.
  • Improved outcomes in crossdocking and enrichment studies across multiple systems.
  • Successful retrospective virtual screening analyses for key drug targets.

Conclusions:

  • The FMS scoring function significantly enhances the accuracy and success rate of molecular docking.
  • This method offers a valuable tool for the computational drug discovery community using DOCK.
  • The FMS method provides fundamental insights for guiding drug lead identification and design.